BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
BioNTech SE (BNTX) Reports Q4 EPS of EUR12.18
March 30, 2022 6:05 AM EDTBioNTech SE (NASDAQ: BNTX) reported Q4 EPS of EUR12.18. Revenue for the quarter came in at EUR5.53 billion.
Estimated BioNTech COVID-19 vaccine revenues for the full 2022 financial year 13 billion - 17 billion
For earnings history and earnings-related data on BioNTech SE (BNTX) click here.
... More